Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
53 Leser
Artikel bewerten:
(0)

United States Contrast Agents and Injectors Market Overview 2016 - Research and Markets

DUBLIN, October 12, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "US Market Report for Contrast Agents and Injectors 2016 - MedCore" report to their offering.

The U.S. market for contrast agents and injectors includes X-ray and CT agents, MRI agents and ultrasound agents as well as contrast injectors. In 2015, MRI contrast agents represented the largest segment in the contrast agent and injector market. This segment will continue to have the highest market value driven by increasing procedural volumes.

This market value does not include the contrast injector segment, as it is a capital-based market instead of consumable-based. In 2015, the MRI contrast agent segment comprised the largest portion of this market. Despite having a lower sales volume, the higher ASP of MRI contrast agents compared to X-Ray CT contrast agents, has allowed this segment to increase in market share.

Conversely, stagnant unit growth and decreasing ASPs has caused the X-Ray CT contrast agent segment to experience a decline in market share. Ultrasound contrast agents command the highest ASP and will exhibit a gradually increasing market share driven by sales growth.

Key Topics Covered:

1. Executive Summary

  • U.S. Medical Imaging Device Market Overview
  • Competitive Analysis
  • Market Trends
  • Market Developments
  • Procedure Codes Investigated
  • Procedures Included
  • Markets Included
  • Key Report Updates

2. Product Assessment
2.1 Product Portfolios
2.1.1 Contrast Agents And Power Injectors
2.2 Regulatory Issues And Recalls
2.2.1 Power Injectors
2.3 Clinical Trials

3. Contrast Agent And Injector Market
3.1 Market Overview
3.2 Market Analysis And Forecast
3.2.1 Total Contrast Agent Market
3.2.2 Contrast Injector Market
3.3 Drivers And Limiters
3.4 Competitive Market Share Analysis

Companies Mentioned

  • Accutome
  • Agfa Healthcare
  • Assured Imaging Mobile Mammography
  • BK Medical
  • Bayer
  • Bracco
  • C.R. Bard
  • CMR-Naviscan
  • Canon
  • Carestream Health
  • Cuattro
  • Fischer-Giotto
  • Fujifilm
  • GE Healthcare
  • Gamma Medica Inc.
  • Imaging Dynamics Company
  • Konica Minolta
  • Lakeshore Technologies Inc.
  • Lantheus Medical Imaging
  • MILabs
  • Machnet B.V.
  • Mallinckrodt
  • Mindray
  • Neusoft Medical Systems
  • Paradigm
  • Philips Healthcare
  • Planmed OY
  • Quantel Medical
  • Rayence
  • Samsung Medison
  • Shimadzu
  • Siemens Healthcare
  • Spectrum Dynamics Medical
  • SuperSonic Imagine
  • Swissray

For more information about this report visit http://www.researchandmarkets.com/research/smbnq9/us_market_report

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.